Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2016-09-28

Clinical Trial Update: Study to Determine the Effect of Azasite on Corneal Surface Irregularity [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating azithromycin ophthalmic solution (Azasite) for corneal surface irregularity associated with Meibomian Gland Dysfunction has been with…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • AZASITE (AZITHROMYCIN MONOHYDRATE)

Snippet

Sponsor: Philadelphia Eye Associates | Conditions: Meibomian Gland Dysfunction | Phase 2 | Status: WITHDRAWN